Zhende Medical(SH:603301) Zheng Quan Zhi Xing·2025-07-23 16:23Core Viewpoint - The company plans to change the purpose of repurchased shares from "for employee stock ownership plan" to "cancel and reduce registered capital" for 615,667 shares, which represents 0.23% of the total share capital [1][2][4]. Summary by Sections Share Repurchase Implementation - The company approved a share repurchase plan on December 31, 2020, with a total fund of no less than RMB 120 million and no more than RMB 160 million, to be completed within 12 months [2]. - The repurchase price was capped at RMB 72.00 per share, with a total transaction amount of RMB 12 million [2]. Change of Purpose and Cancellation - The board of directors agreed to change the purpose of the repurchased shares from "for employee stock ownership plan" to "cancel and reduce registered capital" due to the failure to unlock shares in the first employee stock ownership plan [3][4]. - After the cancellation, the total share capital will decrease from 266,451,202 shares to 265,835,535 shares, and registered capital will reduce from RMB 266,451,202 to RMB 265,835,535 [1][4]. Impact of the Change - The change in the purpose of repurchased shares and cancellation is expected to have no significant impact on the company's financial status or operational results, nor will it affect the company's debt repayment ability or ongoing operations [5][6]. - The company maintains that this decision does not harm the interests of shareholders, especially minority shareholders, and will not lead to changes in the controlling shareholder or actual controller [6]. Decision-Making Process - The decision was made during the 22nd meeting of the third board of directors and the 19th meeting of the third supervisory board on July 23, 2025, and requires approval from the shareholders' meeting [6][7]. - The supervisory board supports the decision, confirming that it complies with relevant regulations and does not harm the interests of the company or its shareholders [7].